seed
Stage
About
Permeasis develops a proprietary technology platform enabling intracellular delivery of biologically active macromolecules such as proteins, aiming to expand therapeutic options to diseases currently inaccessible by conventional biologics or small molecules.
Explore Permeasis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.